Jacobs & Co’s Eli Lilly LLY Stock Holding History

Jacobs & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.8M	Sell	29,017 -1,764	-6%	-$1.8M	2.98%	5
2026 Q1	$28.3M	Buy	30,781 +140	+0.5%	+$142K	2.79%	5
2025 Q4	$32.9M	Sell	30,641 -719	-2%	-$687K	3.11%	4
2025 Q3	$23.9M	Buy	31,360 +755	+2%	+$562K	2.29%	7
2025 Q2	$23.9M	Buy	30,605 +793	+3%	+$616K	2.37%	8
2025 Q1	$24.6M	Buy	29,812 +421	+1%	+$350K	2.62%	7
2024 Q4	$22.7M	Buy	29,391 +7,646	+35%	+$6.33M	2.31%	8
2024 Q3	$19.3M	Sell	21,745 -231	-1%	-$208K	1.93%	8
2024 Q2	$19.9M	Sell	21,976 -554	-2%	-$443K	2.09%	9
2024 Q1	$17.5M	Sell	22,530 -858	-4%	-$611K	1.86%	9
2023 Q4	$13.6M	Sell	23,388 -1,263	-5%	-$737K	1.55%	18
2023 Q3	$13.2M	Sell	24,651 -909	-4%	-$468K	1.65%	14
2023 Q2	$12M	Sell	25,560 -1,874	-7%	-$786K	1.43%	24
2023 Q1	$9.42M	Buy	27,434 +290	+1%	+$97.8K	1.16%	40
2022 Q4	$9.93M	Sell	27,144 -260	-0.9%	-$92.2K	1.29%	33
2022 Q3	$8.86M	Sell	27,404 -563	-2%	-$178K	1.27%	31
2022 Q2	$9.07M	Sell	27,967 -359	-1%	-$108K	1.21%	40
2022 Q1	$8.11M	Sell	28,326 -485	-2%	-$125K	0.9%	54
2021 Q4	$7.96M	Sell	28,811 -755	-3%	-$191K	0.83%	56
2021 Q3	$6.83M	Sell	29,566 -401	-1%	-$99K	0.79%	59
2021 Q2	$6.88M	Sell	29,967 -1,158	-4%	-$233K	0.79%	56
2021 Q1	$5.81M	Sell	31,125 -586	-2%	-$115K	0.71%	59
2020 Q4	$5.35M	Buy	31,711 +815	+3%	+$122K	0.7%	59
2020 Q3	$4.57M	Sell	30,896 -1,668	-5%	-$258K	0.66%	60
2020 Q2	$5.35M	Sell	32,564 -131	-0.4%	-$20.1K	0.87%	47
2020 Q1	$4.54M	Sell	32,695 -575	-2%	-$79K	0.88%	46
2019 Q4	$4.37M	Buy	33,270 +1,284	+4%	+$149K	0.66%	62
2019 Q3	$3.58M	Sell	31,986 -731	-2%	-$81.4K	0.58%	64
2019 Q2	$3.62M	Buy	32,717 +900	+3%	+$106K	0.58%	63
2019 Q1	$4.13M	Sell	31,817 -6,174	-16%	-$751K	0.7%	58
2018 Q4	$4.4M	Sell	37,991 -2,129	-5%	-$238K	0.87%	46
2018 Q3	$4.3M	Sell	40,120 -2,337	-6%	-$234K	0.73%	52
2018 Q2	$3.62M	Sell	42,457 -63	-0.1%	-$5.17K	0.66%	59
2018 Q1	$3.29M	Sell	42,520 -1,407	-3%	-$113K	0.61%	61
2017 Q4	$3.71M	Sell	43,927 -615	-1%	-$52.3K	0.67%	60
2017 Q3	$3.81M	Sell	44,542 -1,677	-4%	-$138K	0.72%	59
2017 Q2	$3.8M	Sell	46,219 -274	-0.6%	-$22.4K	0.75%	57
2017 Q1	$3.91M	Sell	46,493 -1,581	-3%	-$127K	0.8%	53
2016 Q4	$3.54M	Sell	48,074 -140	-0.3%	-$10.4K	0.77%	54
2016 Q3	$3.87M	Sell	48,214 -175	-0.4%	-$14K	0.86%	49
2016 Q2	$3.81M	Sell	48,389 -965	-2%	-$72.7K	0.9%	48
2016 Q1	$3.55M	Sell	49,354 -215	-0.4%	-$16.3K	0.86%	50
2015 Q4	$3.98M	Sell	49,569 -2,085	-4%	-$173K	1.03%	40
2015 Q3	$4.32M	Sell	51,654 -686	-1%	-$57.9K	1.15%	38
2015 Q2	$4.37M	Sell	52,340 -2,281	-4%	-$174K	1.09%	39
2015 Q1	$3.97M	Buy	54,621 +225	+0.4%	+$16K	1.01%	44
2014 Q4	$3.75M	Buy	54,396 +679	+1%	+$45.8K	0.99%	43
2014 Q3	$3.48M	Sell	53,717 -150	-0.3%	-$9.5K	0.99%	42
2014 Q2	$3.35M	Sell	53,867 -1,117	-2%	-$66.6K	0.97%	45
2014 Q1	$3.24M	Sell	54,984 -1,010	-2%	-$56.4K	1%	39
2013 Q4	$2.85M	Sell	55,994 -200	-0.4%	-$10K	0.91%	48
2013 Q3	$2.83M	Sell	56,194 -1,800	-3%	-$94.2K	0.98%	43
2013 Q2	$2.85M	Buy	+57,994	New	+$3.16M	1.03%	39

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Jacobs & Co's LLY Position: Q2 2026 in Review

Jacobs & Co reduced its Eli Lilly (LLY) stake by 5.7% in Q2 2026, selling an estimated $1.8M and leaving 29,017 shares worth $34.8M. The position accounts for 2.98% of the portfolio, ranked #5.

Jacobs & Co first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Jacobs & Co held 29,017 shares of Eli Lilly worth $34.8M as of Q2 2026.
Jacobs & Co sold 1,764 Eli Lilly shares in Q2 2026, an estimated $1.8M.
Eli Lilly made up 2.98% of Jacobs & Co's portfolio in Q2 2026, its #5 holding.
Jacobs & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.